X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (487) 487
humans (472) 472
vaginal creams, foams, and jellies (249) 249
index medicus (234) 234
adult (226) 226
vaginal creams, foams, and jellies - therapeutic use (174) 174
administration, intravaginal (163) 163
middle aged (159) 159
obstetrics & gynecology (108) 108
hiv infections - prevention & control (100) 100
vaginal creams, foams, and jellies - administration & dosage (90) 90
adolescent (83) 83
pharmacology & pharmacy (80) 80
treatment outcome (76) 76
women (74) 74
prevention (72) 72
young adult (69) 69
pregnancy (67) 67
hiv (65) 65
male (64) 64
infectious diseases (63) 63
double-blind method (62) 62
aged (61) 61
vagina - drug effects (61) 61
animals (57) 57
clinical trials (49) 49
vagina - pathology (48) 48
gels (45) 45
vagina (44) 44
vaginosis, bacterial - drug therapy (44) 44
analysis (43) 43
candidiasis, vulvovaginal - drug therapy (43) 43
anti-hiv agents - therapeutic use (42) 42
sexual behavior (42) 42
human immunodeficiency virus--hiv (41) 41
menopause (40) 40
atrophy (39) 39
public, environmental & occupational health (39) 39
anti-infective agents, local - therapeutic use (37) 37
estrogens - therapeutic use (37) 37
vaginal diseases - drug therapy (37) 37
anti-infective agents - administration & dosage (36) 36
anti-infective agents - therapeutic use (36) 36
hiv prevention (36) 36
postmenopause (36) 36
anti-hiv agents - administration & dosage (35) 35
anti-infective agents (35) 35
hiv infections - transmission (35) 35
postmenopausal women (35) 35
bacterial vaginosis (34) 34
infection (34) 34
obstetrics and gynecology (34) 34
anti-bacterial agents - therapeutic use (33) 33
microbicides (33) 33
research (32) 32
health aspects (31) 31
sexually transmitted diseases (31) 31
vaginal creams, foams, and jellies - chemistry (31) 31
article (30) 30
efficacy (30) 30
microbiology (30) 30
sexually transmitted diseases - prevention & control (30) 30
tenofovir (30) 30
estrogen (29) 29
prevalence (29) 29
hiv infection (28) 28
safety (28) 28
microbicide (27) 27
acceptability (26) 26
clinical trials as topic (26) 26
hydrogen-ion concentration (26) 26
medicine, general & internal (26) 26
transmission (26) 26
women's health (26) 26
antiviral agents (25) 25
follow-up studies (25) 25
gel (25) 25
infections (25) 25
risk (25) 25
time factors (25) 25
vagina - microbiology (25) 25
care and treatment (24) 24
disease prevention (24) 24
immunology (24) 24
progesterone - administration & dosage (24) 24
prospective studies (24) 24
antifungal agents - therapeutic use (23) 23
drug delivery systems (23) 23
south africa (23) 23
therapy (23) 23
usage (23) 23
vaginal creams, foams, and jellies - pharmacology (23) 23
adenine - analogs & derivatives (22) 22
administration, topical (22) 22
dyspareunia - drug therapy (22) 22
estrogens - administration & dosage (22) 22
management (22) 22
risk factors (22) 22
vaginal creams, foams, and jellies - adverse effects (22) 22
aids (21) 21
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (471) 471
Bulgarian (16) 16
Italian (11) 11
German (5) 5
Spanish (5) 5
French (4) 4
Chinese (2) 2
Portuguese (2) 2
Croatian (1) 1
Polish (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Science, ISSN 0036-8075, 9/2010, Volume 329, Issue 5996, pp. 1168 - 1174
The Centre for the AIDS Program of Research in South Africa (CAPRISA) 004 trial assessed the effectiveness and safety of a 1% vaginal gel formulation of... 
Human sexual behavior | HIV infections | Antiinfectives | Gels | HIV | RESEARCH ARTICLES | Placebos | Experimentation | AIDS | Infections | Condoms | VAGINAL GEL | INDIVIDUALS | SOUTH-AFRICA | PROPHYLAXIS | IN-VITRO | TRANSMISSION | MULTIDISCIPLINARY SCIENCES | CLINICAL-TRIALS | MALE CIRCUMCISION | RANDOMIZED CONTROLLED-TRIAL | CHALLENGES | HIV Infections - prevention & control | Anti-Infective Agents, Local - therapeutic use | Urban Population - statistics & numerical data | HIV Infections - epidemiology | Humans | Anti-Infective Agents, Local - adverse effects | Drug Resistance, Viral | Administration, Intravaginal | Viral Load | Incidence | Anti-HIV Agents - administration & dosage | Tenofovir | Young Adult | Adenine - adverse effects | HIV-1 - physiology | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Vaginal Creams, Foams, and Jellies | Rural Population - statistics & numerical data | Sexual Behavior | Adenine - analogs & derivatives | Double-Blind Method | Organophosphonates - therapeutic use | HIV-1 - drug effects | Anti-HIV Agents - adverse effects | South Africa - epidemiology | Organophosphonates - adverse effects | Adenine - administration & dosage | Pregnancy | Organophosphonates - administration & dosage | Anti-Infective Agents, Local - administration & dosage | Adolescent | Patient Compliance | Pregnancy Outcome | Prevention | Anti-infective agents | Research | HIV infection
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 09/2015, Volume 92, pp. 105 - 122
Journal Article
Journal Article
Contraception, ISSN 0010-7824, 2010, Volume 82, Issue 5, pp. 410 - 417
Abstract The synthetic progestins used for contraception so far are structurally related either to testosterone (estranes and gonanes) or to progesterone... 
Obstetrics and Gynecology | Breast cancer risk | CNS | Contraception | Progesterone | Thrombosis | Progestins | NOMEGESTROL ACETATE | PERIPHERAL BETA-ENDORPHIN | OBSTETRICS & GYNECOLOGY | IN-VITRO | ETHINYL ESTRADIOL | PROFILE | PROGESTOGENS | DROSPIRENONE | ORAL-CONTRACEPTIVES | OVARIAN-FUNCTION | Contraceptives, Oral, Synthetic - adverse effects | Contraceptive Agents, Female - pharmacology | Contraceptive Agents, Female - therapeutic use | Contraceptives, Oral, Synthetic - therapeutic use | Progestins - therapeutic use | Humans | Contraceptive Agents, Female - administration & dosage | Vaginal Creams, Foams, and Jellies - adverse effects | Contraceptives, Oral, Synthetic - pharmacology | Vaginal Creams, Foams, and Jellies - therapeutic use | Young Adult | Contraceptive Devices, Female - trends | Progesterone Congeners - pharmacology | Adult | Female | Contraception - methods | Vaginal Creams, Foams, and Jellies - pharmacology | Contraception - trends | Progesterone Congeners - therapeutic use | Progestins - pharmacology | Contraceptives, Oral, Combined - adverse effects | Contraceptives, Oral, Combined - therapeutic use | Animals | Contraceptives, Oral, Combined - pharmacology | Progestins - administration & dosage | Adolescent | Progesterone Congeners - administration & dosage | Testosterone | Ethinyl estradiol | Corticosteroids | Estradiol | Side effects
Journal Article
Journal Article
Journal Article
Advanced Drug Delivery Reviews, ISSN 0169-409X, 09/2015, Volume 92, pp. 53 - 70
Journal Article